- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Researchers clash over AAA screening's worth
Two European studies published on the same day have reached opposite conclusions about the cost-effectiveness of ultrasound screening exams for abdominal aortic aneurysm.
Two European studies published on the same day have reached opposite conclusions about the cost-effectiveness of ultrasound screening exams for abdominal aortic aneurysm.
Researchers in the U.K. came to a positive conclusion about the exam's cost-effectiveness based on nearly 70,000 subjects enrolled in the Multicenter Aneurysm Screening Study (MASS). A cost/benefit analysis showed average per-life-year gains below the National Health Service's benchmark of £25,000. Danish investigators, on the other hand, reported negative findings using a mathematical model and data from the literature and the Danish Vascular Registry to estimate costs and outcomes for a hypothetical population of Danish men aged 65 from screening to death. Their estimates showed the cost of screening per quality adjusted life year was $71,160, well beyond the local accepted benchmark of $49,530. Both studies were published online June 26 in the British Medical Journal.
PET Agent Gets FDA Fast Track Designation for Cardiac AL and ATTR Amyloidosis
January 22nd 2025Previously approved for the detection of neuritic beta amyloid plaque, the PET agent (18F)florbetaben is currently being evaluated in a phase 3 multicenter trial for the diagnosis of cardiac amyloidosis.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
